Nocturia Market Size Analysis, Growth by Top Companies, Trends by Types and Application, Forecast Analysis to 2025

Nocturia is the medical condition referred to the excessive urination at night. This is more common in the geriatric population and occurs in both men and women. Normally, during sleep time, human body produces less urine and that is more concentrated and most people don’t need to wake up during the night to urinate and can sleep uninterrupted for 6 to 8 hours. Its major causes include the range from lifestyle choices to medical conditions such as; sleep disorders, and bladder obstruction, infection or enlargement of the prostate, bladder prolapse, prostate, or pelvic area, tumors of the bladder, diabetes, anxiety, kidney infection, edema or swelling of the lower legs, obstructive sleep apnea, and neurological disorders, such as Parkinson’s disease, or spinal cord compression.

Marvelous March Sale! Get Discount at:

The regions covered in this Nocturia Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of nocturia is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players –

Some major key players for Global Nocturia Market are Allergan, Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, AA Pharma, Avadel Pharmaceuticals and others.

Increasing Geriatric Population Coupled with the Increasing Prevalence of Organ Failure, Such as Heart or Liver Failure Drives the Growth of Global Nocturia Market

The major factor driving the growth of global nocturia market is increasing geriatric population coupled with the increasing prevalence of organ failure, such as heart or liver failure. For example; As per National Center for Biotechnology Information; There is relatively large number of comparative studies confirming strong correlation between aging and prevalence of nocturia. Prevalence of two or more voids per night in individuals in their twenties varies between 5-15 %, it progresses with age, and in the seventh decade of life ranges between 35-50 %.

However, high operational cost may hamper the market growth. In spite of that, increasing advancements in the field of drug delivery systems can provide various opportunities for the further growth of the market.

North America is Expected to Dominate the Global Nocturia Market

The Global Nocturia Market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global nocturia market within the forecast period attributed to the highly developed healthcare infrastructure and increasing cases of nocturia in this region. For example; As per the National Center for Biotechnology Information; Nocturia affects 50 million people in the United States, with 10 million actually diagnosed with nocturia but only 1.5 million receiving specific therapy for it. One in three adults older than age 30 make at least two trips to the bathroom every night, and about 70% of these individuals are bothered by this.

More Details on this Report:

Key Benefits for Market Report–

  • Global Nocturia Market report covers in-depth historical and forecast analysis.
  • Global Nocturia Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global Nocturia Market report helps to identify opportunities in marketplace.
  • Global Nocturia Market report covers extensive analysis of emerging trends and competitive landscape.

Read Other Reports:—2025-2020-02-26